Eczema

The “hygiene hypothesis” suggests that the absence of infectious exposure during infancy could lead to a greater risk of allergic diseases. In a recent study, researchers sought to determine if exposure to...

Although more common in infancy and early childhood, atopic dermatitis can profoundly affect adults as well. Information on treating adults with atopic dermatitis was presented at the 2017 American Academy...

The US Food and Drug Administration has approved Dupixent for the treatment of moderate-to-severe eczema in adults.

Researchers sought to determine the effectiveness of oral and topical antibiotics and corticosteroids in treating clinically infected eczema in children.

The FDA has approved a new ointment for the treatment of mild-to-moderate eczema in patients aged 2 years and older.

By Reuters Staff

The FDA has approved Eucrisa (crisaborole) ointment for the treatment of mild to moderate eczema (atopic dermatitis) in patients aged 2 years and older.

New research shows how atopic dermatitis early in life influences the development of hand eczema later in life.

When pregnant or breastfeeding mothers take probiotics or give them to their infants, the child's risk of eczema may be reduced, a new research review suggests.